Shockwave Medical, Inc.
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $730.2M | $489.7M | $237.1M | $67.8M | $42.9M | $12.3M |
| Operating income | $159.1M | $124.1M | −$871,000 | −$65.7M | −$51.8M | −$41.2M |
| Net income | $147.3M | $216.0M | −$9.1M | −$65.7M | −$51.1M | −$41.1M |
| Total assets | $1.57B | $646.1M | $345.7M | $272.0M | $231.9M | $53.4M |
| Total liabilities | $897.9M | $134.8M | $103.9M | $46.4M | $39.3M | $23.2M |
| Equity | $668.7M | $511.3M | $241.8M | $225.7M | $192.7M | −$122.6M |
| EPS (diluted) | $3.85 | $5.70 | $-0.26 | $-1.99 | — | — |
| Shares out. | 36.5M | 35.7M | 34.8M | 31.8M | 31.4M | 1.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- 21.8%
- Net margin
- 20.2%
- Return on equity
- 22.0%
- Return on assets
- 9.4%
- Return on capital (ROCE)
- 10.9%
- Liabilities / assets
- 57.3%
- Debt / equity
- 1.34×
- Book value / share
- $18.32
- Revenue growth (YoY)
- 49.1%
- Net income growth (YoY)
- −31.8%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- 6.39safe
- Accruals / assets
- −3.1%clean
- Beneish M-Score
- -2.82normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 6 good- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Completed an acquisition or disposition · Debt acceleration / triggering event · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosureMay 31, 2024
- Shareholder voteMay 30, 2024
- Other material eventMay 21, 2024
- Results of operationsMay 6, 2024
- Director / officer changeApr 9, 2024
- Entered a material agreement · Regulation FD disclosureApr 5, 2024
- Changed auditorMar 1, 2024
- Results of operationsFeb 15, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.